News and resources | Resources
Video 17 November 2016

The Exciting Journey from Flu Virus to Vaccine

By IFPMA
Downloads
Video
Share
Topics
InfluenzaVaccines

Ever wondered how your flu vaccine is made? Look no further.

This video illustrates the different surveillance activities needed to target the right virus before the manufacturing process begins.

For more information on the manufacturing process, click here.

 

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.

Learn more

Media Contact

Elliot Dunster

Related news and resources

Statement 6 Jun 2023

G20 side event on “Envisaging a Global R&D Network for Research in Vaccines, Therapeutics, and Diagnostics (VTDs) to enhance Prevention, Preparedness, and Response (PPR)”

On 6 June, IFPMA delivered a statement at the G20 “Strengthening Global Collaboration on Research and Development in MCMs (Diagnostics, Vaccines, and Therapeutics” side event on “Envisaging a Global R&D Network for Research in VTDs to enhance PPR” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Statement 5 Jun 2023

G20 side event on Global Vaccine Research Collaborative

On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Position paper 27 Mar 2023

No-Fault Compensation (NFC) systems and legislative liability protections for pandemic vaccines

This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.

Read more
Top